Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions

Kirsten Fischer, Othman Al-Sawaf, Jasmin Bahlo, Anna-Maria Fink, Maneesh Tandon, Mark Dixon, Sandra Robrecht, Simon Warburton, Kathryn Humphrey, Olga Samoylova, Anna M. Liberati, Javier Pinilla-Ibarz, Stephen Opat, Liliya Sivcheva, Katell Le Dû, Laura M. Fogliatto, Carsten U. Niemann, Robert Weinkove, Sue Robinson, Thomas J. Kipps, Sebastian Boettcher, Eugen Tausch, Rod Humerickhouse, Barbara Eichhorst, Clemens-Martin Wendtner, Anton W. Langerak, Karl-Anton Kreuzer, Matthias Ritgen, Valentin Goede, Stephan Stilgenbauer, Mehrdad Mobasher, Michael Hallek

Open source

DOI: 10.1056/nejmoa1815281
Published: 2019-06-06
Container: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa1815281,
  title = {Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions},
  author = {Kirsten Fischer and Othman Al-Sawaf and Jasmin Bahlo and Anna-Maria Fink and Maneesh Tandon and Mark Dixon and Sandra Robrecht and Simon Warburton and Kathryn Humphrey and Olga Samoylova and Anna M. Liberati and Javier Pinilla-Ibarz and Stephen Opat and Liliya Sivcheva and Katell Le Dû and Laura M. Fogliatto and Carsten U. Niemann and Robert Weinkove and Sue Robinson and Thomas J. Kipps and Sebastian Boettcher and Eugen Tausch and Rod Humerickhouse and Barbara Eichhorst and Clemens-Martin Wendtner and Anton W. Langerak and Karl-Anton Kreuzer and Matthias Ritgen and Valentin Goede and Stephan Stilgenbauer and Mehrdad Mobasher and Michael Hallek},
  year = {2019},
  journal = {New England Journal of Medicine},
  doi = {10.1056/nejmoa1815281},
  url = {https://doi.org/10.1056/nejmoa1815281}
}

RIS

TY  - JOUR
TI  - Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions
AU  - Kirsten Fischer
AU  - Othman Al-Sawaf
AU  - Jasmin Bahlo
AU  - Anna-Maria Fink
AU  - Maneesh Tandon
AU  - Mark Dixon
AU  - Sandra Robrecht
AU  - Simon Warburton
AU  - Kathryn Humphrey
AU  - Olga Samoylova
AU  - Anna M. Liberati
AU  - Javier Pinilla-Ibarz
AU  - Stephen Opat
AU  - Liliya Sivcheva
AU  - Katell Le Dû
AU  - Laura M. Fogliatto
AU  - Carsten U. Niemann
AU  - Robert Weinkove
AU  - Sue Robinson
AU  - Thomas J. Kipps
AU  - Sebastian Boettcher
AU  - Eugen Tausch
AU  - Rod Humerickhouse
AU  - Barbara Eichhorst
AU  - Clemens-Martin Wendtner
AU  - Anton W. Langerak
AU  - Karl-Anton Kreuzer
AU  - Matthias Ritgen
AU  - Valentin Goede
AU  - Stephan Stilgenbauer
AU  - Mehrdad Mobasher
AU  - Michael Hallek
PY  - 2019
JO  - New England Journal of Medicine
DO  - 10.1056/nejmoa1815281
UR  - https://doi.org/10.1056/nejmoa1815281
ER  -

APA

Fischer, K., Al-Sawaf, O., Bahlo, J., Fink, A., Tandon, M., Dixon, M., Robrecht, S., Warburton, S., Humphrey, K., Samoylova, O., Liberati, A. M., Pinilla-Ibarz, J., Opat, S., Sivcheva, L., Dû, K. L., Fogliatto, L. M., Niemann, C. U., Weinkove, R., Robinson, S., Kipps, T. J., Boettcher, S., Tausch, E., Humerickhouse, R., Eichhorst, B., Wendtner, C., Langerak, A. W., Kreuzer, K., Ritgen, M., Goede, V., Stilgenbauer, S., Mobasher, M., & Hallek, M. (2019). Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1815281

Source records

crossref · retrieved 2026-09-25T15:27:18.773Z